New Treatment Approved for Prostate Cancer That Resists Hormone Therapy
WEDNESDAY, Feb. 14, 2018 -- Erleada (apalutamide) has been approved by the U.S. Food and Drug Administration to treat non-spreading prostate cancer that continues to grow despite hormone therapy.
Prostate cancer is the second-most-common form of the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | General Medicine | Hormonal Therapy | Hormones | Prostate Cancer